HOLLER FRANK A 4
4 · Xenon Pharmaceuticals Inc. · Filed Jun 2, 2020
Insider Transaction Report
Form 4
HOLLER FRANK A
Director
Transactions
- Exercise/Conversion
Common Shares
2020-05-29$3.56/sh+3,086$10,986→ 122,041 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-29−3,086→ 0 totalExercise: $3.56Exp: 2020-06-02→ Common Shares (3,086 underlying) - Award
Stock Option (Right to Buy)
2020-06-01+10,000→ 10,000 totalExercise: $13.11Exp: 2030-05-31→ Common Shares (10,000 underlying)
Holdings
- 1,184(indirect: By Spouse)
Common Shares
Footnotes (5)
- [F1]The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise
- [F2]The shares held indirectly by the Reporting Person's spouse were inadvertently omitted from the Form 4 filed on September 20, 2019.
- [F3]The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.
- [F4]Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period.
- [F5]One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.